Robert S. Mills - 15 Aug 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Robert S. Mills by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Aug 2023
Net transactions value
+$10,000
Form type
4
Filing time
15 Aug 2023, 08:00:07 UTC
Previous filing
30 Dec 2022
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Purchase $10,000 +40,000 +250% $0.2500 55,980 15 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.